Morgan Stanley’s Acumen Pharmaceuticals ABOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Buy |
153,748
+1,112
| +0.7% | +$1.29K | ﹤0.01% | 5897 |
|
|
2025
Q1 | $168K | Sell |
152,636
-113,580
| -43% | -$125K | ﹤0.01% | 5810 |
|
|
2024
Q4 | $458K | Buy |
266,216
+27,016
| +11% | +$46.5K | ﹤0.01% | 5454 |
|
|
2024
Q3 | $593K | Buy |
239,200
+151,391
| +172% | +$375K | ﹤0.01% | 5318 |
|
|
2024
Q2 | $212K | Buy |
87,809
+39,097
| +80% | +$94.6K | ﹤0.01% | 5646 |
|
|
2024
Q1 | $197K | Buy |
48,712
+2,460
| +5% | +$9.96K | ﹤0.01% | 5742 |
|
|
2023
Q4 | $178K | Buy |
46,252
+24,013
| +108% | +$92.2K | ﹤0.01% | 5989 |
|
|
2023
Q3 | $92.3K | Buy |
22,239
+6,915
| +45% | +$28.7K | ﹤0.01% | 5929 |
|
|
2023
Q2 | $73.7K | Sell |
15,324
-36,184
| -70% | -$174K | ﹤0.01% | 6067 |
|
|
2023
Q1 | $209K | Buy |
51,508
+25,824
| +101% | +$105K | ﹤0.01% | 5689 |
|
|
2022
Q4 | $139K | Buy |
25,684
+6,770
| +36% | +$36.6K | ﹤0.01% | 5824 |
|
|
2022
Q3 | $189K | Sell |
18,914
-5,283
| -22% | -$52.8K | ﹤0.01% | 5749 |
|
|
2022
Q2 | $114K | Buy |
24,197
+10,510
| +77% | +$49.5K | ﹤0.01% | 6200 |
|
|
2022
Q1 | $53K | Sell |
13,687
-6,946
| -34% | -$26.9K | ﹤0.01% | 6674 |
|
|
2021
Q4 | $139K | Buy |
20,633
+20,064
| +3,526% | +$135K | ﹤0.01% | 6258 |
|
|
2021
Q3 | $8K | Buy |
+569
| New | +$8K | ﹤0.01% | 7384 |
|